Loading insider details...
Beta
Latest Form 4 (May 4, 2026): Grant/Award of 49,033 SPTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 4, 2026 | Seaport Therapeutics, Inc. (SPTX) | Grant/Award | 49,033 | n/a |
| Jan 26, 2026 | Benitec Biopharma Inc. (BNTC) | Grant/Award | 31,500 | n/a |
| Dec 3, 2025 | Benitec Biopharma Inc. (BNTC) | Grant/Award | 3,500 | n/a |
| Nov 8, 2025 | Benitec Biopharma Inc. (BNTC) | Grant/Award | 28,517 | n/a |
| Aug 30, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Exercise/Conversion | 35,604 | $453.2K |
| Aug 28, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Exercise/Conversion | 22,713 | $399.1K |
| Aug 23, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Exercise/Conversion | 53,013 | $931.4K |
| Apr 25, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Exercise/Conversion | 8,638 | $145.6K |
| Mar 11, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Sale | 31,958 | $2.12M |
| Mar 8, 2024 | Intra-Cellular Therapies, Inc. (ITCI) | Exercise/Conversion | 40,712 | n/a |